Completed PHASE4 INTERVENTIONAL 1-arm NCT01591616

Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel

A Phase 4 Pediatric Study to Assess the Pharmacokinetics and Safety of Oraqix Gel in Healthy Children and Adolescent Volunteers Following Tooth Extraction

Sponsor: Dentsply International

Conditions Periodontal Disease

Interventions lidocaine and prilocaine

Updated 8 times since 2017 Last updated: Jul 21, 2020 Started: Apr 30, 2010 Primary completion: Apr 30, 2012 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01591616, this PHASE4 trial focuses on Periodontal Disease and remains completed. Sponsored by Dentsply International, it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Oct 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Oct 2022 [monthly]

Completed PHASE4
Sep 2020 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Sep 2020 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dentsply International

Data source: Dentsply Sirona Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Richmond, United States